SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
response after non
on 01 Nov 2024
Last Applicant/ Owned by
180 3rd Avenue, Fifth Floor
Waltham
MA
02451
Serial Number
90590474 filed on 19th Mar 2021
Registration Number
N/A
Correspondent Address
Peter Kunin
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SKYSEQ
Research and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases using integrated and high-throughput screening technologies coupled with next-generation sequencing
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases using integrated and high-throughput screening technologies coupled with next-generation sequencing
First Use Date in General
08th Apr 2024
First Use Date in Commerce
08th Apr 2024
Mark Details
Serial Number
No 90590474
Mark Type
No Service Mark
Attorney Docket Number
No 16694007UST1
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 01st Nov 2024 | ASSIGNED TO LIE |
| 01st Nov 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 01st Nov 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 24th Oct 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 18th Oct 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 18th Oct 2024 | SU - NON-FINAL ACTION - WRITTEN |
| 18th Oct 2024 | NON-FINAL ACTION E-MAILED |
| 27th Aug 2024 | SOU TEAS EXTENSION RECEIVED |
| 06th Jul 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 06th Jul 2024 | STATEMENT OF USE PROCESSING COMPLETE |